Edifice Health Trial Tests Supplement Formulas to Lower Inflammatory Age Score
A terminated RCT explored whether immunotype-targeted supplements could reduce iAgeยฎ, an AI-derived biomarker of chronic inflammation and immune aging.
20 articles
A terminated RCT explored whether immunotype-targeted supplements could reduce iAgeยฎ, an AI-derived biomarker of chronic inflammation and immune aging.
German study explored how lifelong inflammatory burden contributes to cardiac aging by measuring heart rate variability changes.
Greek researchers investigated whether whey protein can counter inflammation-driven muscle loss in older adults with chronic inflammation.
Spanish researchers tested whether omega-3 supplements and resistance exercise could reduce harmful inflammation in obese older adults.
8-week stress management program shows promise for reducing inflammation and improving well-being in aging adults through mindfulness techniques.
Mayo Clinic study explores whether omega-3s can combat chronic inflammation and improve muscle function during exercise in aging adults.
A completed trial tested whether probiotic and prebiotic supplementation could reduce premature aging-related inflammation in people living with HIV.
12-week trial tested omega-3 rich camelina oil snacks in 91 healthy adults over 65 for anti-inflammatory effects.
Researchers tested sirolimus, metformin, and diclofenac as topical skin treatments to target aging pathways in healthy volunteers.
A completed University of Michigan trial explored how aerobic exercise training alters RAGE-mediated inflammatory pathways in type 2 diabetic adults.
Small study compared continuous vs interval training effects on immune cell response and inflammation markers in healthy adults.
Phase I trial tests selective JAK3 inhibitor with improved safety profile compared to existing treatments for inflammatory conditions.
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
University of Florida study tested whether omega-3s and losartan can preserve walking ability by reducing inflammation in older adults.
A 2-year clinical trial testing Juice Plus+ products against low-grade inflammation and biological aging markers in overweight seniors was terminated before completion.
Small study explores how tofacitinib may address chronic pain that persists even when inflammation is controlled in RA patients.
Small study tests synbiotic supplements to combat age-related immune decline in healthy elderly adults.
Study tests whether omega-3 rich flax oil enhances resistance training benefits for muscle mass and inflammation in older adults.
Small trial compared EPA vs DHA effects on inflammation markers and lipid profiles in metabolic syndrome patients over 4+ years.
Large clinical trial tests whether fish oil components can accelerate healing of stubborn leg ulcers by reducing inflammation.